SLE patients with "IFN-signature" benefited in a clinical trial that used antibodies to interferon receptor (see link below). Therefore, a clinical trial is being conducted to enroll more SLE patients for therapy.
link: Article Anifrolumab, an Anti-Interferon-Alpha Receptor Monoclonal An...